374 related articles for article (PubMed ID: 28799058)
21. Focal and segmental glomerulosclerosis: does prognosis vary with the variants?
Swarnalatha G; Ram R; Ismal KM; Vali S; Sahay M; Dakshinamurty KV
Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):173-81. PubMed ID: 25579744
[TBL] [Abstract][Full Text] [Related]
22. Twenty-seven children with focal segmental glomerulosclerosis: correlation between the segmental location of the glomerular lesions and prognosis.
Ito H; Yoshikawa N; Aozai F; Hazikano H; Sakaguchi H; Akamatsu R; Matsuo T; Matsuyama S
Clin Nephrol; 1984 Jul; 22(1):9-14. PubMed ID: 6478668
[TBL] [Abstract][Full Text] [Related]
23. The parietal epithelial cell is crucially involved in human idiopathic focal segmental glomerulosclerosis.
Dijkman H; Smeets B; van der Laak J; Steenbergen E; Wetzels J
Kidney Int; 2005 Oct; 68(4):1562-72. PubMed ID: 16164633
[TBL] [Abstract][Full Text] [Related]
24. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
Pereira LHM; da Silva CA; Monteiro MLGDR; Araújo LS; Rocha LP; Reis MBDR; Ramalho FS; Corrêa RRM; Silva MV; Reis MA; Machado JR
PLoS One; 2019; 14(6):e0217569. PubMed ID: 31188898
[TBL] [Abstract][Full Text] [Related]
25. Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis.
Zhang YM; Gu QH; Huang J; Qu Z; Wang X; Meng LQ; Wang F; Liu G; Cui Z; Zhao MH
Clin J Am Soc Nephrol; 2016 Sep; 11(9):1582-1589. PubMed ID: 27340287
[TBL] [Abstract][Full Text] [Related]
26. Lessons from studies on focal segmental glomerulosclerosis: an important role for parietal epithelial cells?
Smeets B; Dijkman HB; Wetzels JF; Steenbergen EJ
J Pathol; 2006 Nov; 210(3):263-72. PubMed ID: 16924588
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of C4d expression and staining patterns by immunohistochemistry in renal biopsy samples with focal segmental glomerulosclerosis and minimal change disease.
Abedi M; Nili F; Dehkhoda F; Abdollahi A; Salarvand S
Ann Diagn Pathol; 2024 Jun; 70():152281. PubMed ID: 38417352
[TBL] [Abstract][Full Text] [Related]
28. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study.
Weber CL; Rose CL; Magil AB
Nephrol Dial Transplant; 2009 Feb; 24(2):483-8. PubMed ID: 18786972
[TBL] [Abstract][Full Text] [Related]
29. Compound effects of aging and experimental FSGS on glomerular epithelial cells.
Schneider RR; Eng DG; Kutz JN; Sweetwyne MT; Pippin JW; Shankland SJ
Aging (Albany NY); 2017 Feb; 9(2):524-546. PubMed ID: 28222042
[TBL] [Abstract][Full Text] [Related]
30. [Long-term prognosis of primary focal segmental glomerulosclerosis in children].
Peng YC; Gao CL; Sun T; Zhang P; Xia ZK
Zhonghua Er Ke Za Zhi; 2022 Sep; 60(9):894-900. PubMed ID: 36038298
[No Abstract] [Full Text] [Related]
31. LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.
Shah L; Hooper DK; Okamura D; Wallace D; Moodalbail D; Gluck C; Koziell A; Zaritsky JJ
Pediatr Nephrol; 2019 Nov; 34(11):2343-2350. PubMed ID: 31250206
[TBL] [Abstract][Full Text] [Related]
32. Primary FSGS in Nephrotic Adults: Clinical Profile, Response to Immunosuppression and Outcome.
Bagchi S; Agarwal S; Kalaivani M; Bhowmik D; Singh G; Mahajan S; Dinda A
Nephron; 2016; 132(2):81-5. PubMed ID: 26799973
[TBL] [Abstract][Full Text] [Related]
33. Glomerular podocyte vacuolation in focal segmental glomerulosclerosis.
Yoshikawa N; Ito H; Akamatsu R; Hazikano H; Okada S; Matsuo T
Arch Pathol Lab Med; 1986 May; 110(5):394-8. PubMed ID: 3754422
[TBL] [Abstract][Full Text] [Related]
34. Differential risk of remission and ESRD in childhood FSGS.
Gipson DS; Chin H; Presler TP; Jennette C; Ferris ME; Massengill S; Gibson K; Thomas DB
Pediatr Nephrol; 2006 Mar; 21(3):344-9. PubMed ID: 16395603
[TBL] [Abstract][Full Text] [Related]
35. Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant.
Fatima H; Moeller MJ; Smeets B; Yang HC; D'Agati VD; Alpers CE; Fogo AB
Clin J Am Soc Nephrol; 2012 Nov; 7(11):1852-8. PubMed ID: 22917699
[TBL] [Abstract][Full Text] [Related]
36. A prospective study of collapsing focal segmental glomerulosclerosis.
Raja R; Nada R; Yadav AK; Kumar A; Goyal A; Kumar V; Rathi M; Kohli HS; Gupta KL; Sakhuja V; Jha V
Ren Fail; 2016 Jul; 38(6):894-8. PubMed ID: 27266801
[TBL] [Abstract][Full Text] [Related]
37. Establishment and characterization of a novel conditionally immortalized human parietal epithelial cell line.
Miesen L; Wetzels R; Eymael J; Mooren F; Villacorta Monge V; van den Berge BT; van den Broek M; van der Velden TJAM; van den Heuvel LPWJ; Wetzels JFM; Schreuder MF; van der Vlag J; Jansen J; Smeets B
Exp Cell Res; 2021 Aug; 405(2):112712. PubMed ID: 34181939
[TBL] [Abstract][Full Text] [Related]
38. Expression of DENDRIN in several glomerular diseases and correlation to pathological parameters and renal failure - preliminary study.
Mizdrak M; Vukojević K; Filipović N; Čapkun V; Benzon B; Durdov MG
Diagn Pathol; 2018 Nov; 13(1):90. PubMed ID: 30458823
[TBL] [Abstract][Full Text] [Related]
39. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
[TBL] [Abstract][Full Text] [Related]
40. Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group.
Kidney Int; 1985 Feb; 27(2):442-9. PubMed ID: 3886999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
